Task: Answer the multiple choice question.
Question: Which drug exhibits a -11.558% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1onc(-c2ccccc2)c1C(=O)Nc1cccc(OC(C)C)c1
(b) COc1cccc(NC(=O)Nc2c(C)n(C)n(-c3ccccc3)c2=O)c1
Answer: a. Cc1onc(-c2ccccc2)c1C(=O)Nc1cccc(OC(C)C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1onc(-c2ccccc2)c1C(=O)Nc1cccc(OC(C)C)c1
Cc1onc(-c2ccccc2)c1C(=O)Nc1cccc(OC(C)C)c1
5-methyl-3-phenyl-N-(3-propan-2-yloxyphenyl)-1,2-oxazole-4-carboxamide